These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25564378)

  • 1. Fluoro-substituted phenylazocarboxamides: Dopaminergic behavior and N-arylating properties for irreversible binding.
    Bartuschat AL; Schellhorn T; Hübner H; Gmeiner P; Heinrich MR
    Bioorg Med Chem; 2015 Jul; 23(14):3938-47. PubMed ID: 25564378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCR targeted library design: novel dopamine D3 receptor ligands.
    Böcker A; Sasse BC; Nietert M; Stark H; Schneider G
    ChemMedChem; 2007 Jul; 2(7):1000-5. PubMed ID: 17477344
    [No Abstract]   [Full Text] [Related]  

  • 4. A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor.
    Hocke C; Maschauer S; Hübner H; Löber S; Utz W; Kuwert T; Gmeiner P; Prante O
    ChemMedChem; 2010 Jun; 5(6):941-8. PubMed ID: 20408162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists.
    Schlotter K; Boeckler F; Hübner H; Gmeiner P
    J Med Chem; 2006 Jun; 49(12):3628-35. PubMed ID: 16759104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel D3 selective dopaminergics incorporating enyne units as nonaromatic catechol bioisosteres: synthesis, bioactivity, and mutagenesis studies.
    Dörfler M; Tschammer N; Hamperl K; Hübner H; Gmeiner P
    J Med Chem; 2008 Nov; 51(21):6829-38. PubMed ID: 18834111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands.
    Du P; Xu L; Huang J; Yu K; Zhao R; Gao B; Jiang H; Zhao W; Zhen X; Fu W
    Chem Biol Drug Des; 2013 Sep; 82(3):326-35. PubMed ID: 23663349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
    Insua I; Alvarado M; Masaguer CF; Iglesias A; Brea J; Loza MI; Carro L
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5586-91. PubMed ID: 24012118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands.
    Zhou B; Ji M; Cai J
    Bioorg Chem; 2018 Apr; 77():125-135. PubMed ID: 29353729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different binding modes of structurally diverse ligands for human D3DAR.
    Ortore G; Tuccinardi T; Orlandini E; Martinelli A
    J Chem Inf Model; 2010 Dec; 50(12):2162-75. PubMed ID: 21090729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M; Renault J; Levoin N; Danvy D; Calmels T; Berrebi-Bertrand I; Robert P; Schwartz JC; Lecomte JM; Uriac P; Capet M
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5376-9. PubMed ID: 20708933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of molecular tools based on the dopamine D
    Stößel A; Brox R; Purkayastha N; Hübner H; Hocke C; Prante O; Gmeiner P
    Bioorg Med Chem; 2017 Jul; 25(13):3491-3499. PubMed ID: 28495386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoMFA and CoMSIA investigations of dopamine D3 receptor ligands leading to the prediction, synthesis, and evaluation of rigidized FAUC 365 analogues.
    Salama I; Schlotter K; Utz W; Hübner H; Gmeiner P; Boeckler F
    Bioorg Med Chem; 2006 Sep; 14(17):5898-912. PubMed ID: 16750374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further SAR study on 11-O-substituted aporphine analogues: identification of highly potent dopamine D3 receptor ligands.
    Ye N; Wu Q; Zhu L; Zheng L; Gao B; Zhen X; Zhang A
    Bioorg Med Chem; 2011 Mar; 19(6):1999-2008. PubMed ID: 21334902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 receptor agonists as pharmacological tools.
    Kassel S; Schwed JS; Stark H
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1480-99. PubMed ID: 25498414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
    Bettinetti L; Löber S; Hübner H; Gmeiner P
    J Comb Chem; 2005; 7(2):309-16. PubMed ID: 15762761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D(3) receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization.
    Micheli F; Holmes I; Arista L; Bonanomi G; Braggio S; Cardullo F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Terreni S; Heidbreder C; Savoia C; Griffante C; Worby A
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4011-3. PubMed ID: 19553113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.
    Holmes IP; Micheli F; Gaines S; Lorthioir O; Watson SP; Fabio RD; Gentile G; Heidbreder C; Savoia C; Worby A
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4799-801. PubMed ID: 19560918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.